iCAD, INC. (NASDAQ:ICAD)
CAPS Rating:
The Company designs, develops, manufactures and markets Computer-Aided Detection solutions that enable healthcare professionals to serve patients by identifying pathologies and pinpointing cancer earlier.
RSS Headlines
Fool UK
Recs
Great potential.
ICAD has quite an impressive balance sheet and is quite undervalued as it is now below a dollar , considering that it has a market for its product.